IMCR

26.4100.83%
KP

Kristine Peterson

Independent Non-Executive Director

Ms. Kristine Peterson, also known as Kris, is Director of Mineralys Therapeutics, Inc. from October 19, 2026. Ms. Peterson is Lead Independent Director of ArriVent BioPharma, Inc. from 2025. Ms. Peterson was Director of ArriVent BioPharma, Inc. from April 2024 to 2025. Ms. Peterson has been an Independent Non-Executive Director at Immunocore Holdings plc since November 2017. Ms. Peterson had been a Non-Executive Director of Amarin Corporation plc since November 18, 2010, until March 07, 2023 and served as Non-Executive Director at Paratek Pharmaceuticals, Inc. since March 2, 2016, until September 21, 2023. She served as the Director at AFYX Therapeutics A/S until 2024. Ms. Peterson served as an Independent Director at EyePoint Pharmaceuticals, Inc. since June 28, 2017, until December 31, 2020. She has been an Independent Director at Enanta Pharmaceuticals, Inc. since September 13, 2017. She had been an Independent Director of ImmunoGen, Inc. since 2012, until February 12, 2024. Ms. Peterson served as the Chief Executive Officer of Valeritas, Inc. from June 2009 to February 22, 2016. Ms. Peterson served as the Chief Executive Officer of Valeritas Holdings, Inc. from June 2009 to February 22, 2016. She served as Senior Vice President of Commercial Operations at Valeant Pharmaceuticals International, Inc. (Alternate Name: Biovail Corporation) from May 2003 to August 2004. She held executive global marketing and commercial roles at Johnson & Johnson from joining in 2004 to 2009 and served as its Group Chair of Biotech Sector, where she was responsible for commercial, R&D and biologics manufacturing for biotech, oncology, immunology and cell therapy. From 2003 to 2009, she served as President and Senior Vice President of Commercial Operations of Biovail Corporation and President of Biovail Pharmaceuticals. Ms. Peterson has senior executive experience in commercial and business leadership roles in the pharmaceutical and biotechnology industry. She spent several years at Bristol-Myers Squibb Company in senior sales and marketing roles of increasing responsibility in a broad range of therapeutic areas that included Cardiovascular, Metabolic, Anti-infective, Virology, Neuroscience, Immunology/Inflammation, Pulmonary and Oncology. She served as Senior Vice President of Marketing for BMS’s Cardiovascular and Metabolic business in the U.S. During her career, she launched several key brands, led large sales organizations and Headed BMS’s generic business. She served as a Director of Valeritas, Inc. from June 2009 to February 25, 2016. She was Executive Vice President of Pharmaceutical Group Strategic Marketing from 2001 to 2006. She served as a Director of Valeritas Holdings, Inc. from June 2009 to February 25, 2016. She served on the internal Board for the BMS Foundation’s Women Health Philanthropy since 2001. She was also a senior advisor to the Healthcare Businesswomen’s Association and a former Member of the Biotechnology Industry Organization Board. She is a Member of the Biotechnology Industry Organization Board. Ms. Peterson holds a BS in Marketing and a master’s in business administration from the University of Illinois at Urbana-Champaign.

Positions